| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ERNA | Stock Option | Award | $0 | +140,580 | $0.000000 | 140,580 | 28 Jun 2021 | Common Stock | 140,580 | $21.35 | Direct | F1 | |
| transaction | ERNA | Restricted Stock Unit | Award | $0 | +70,290 | $0.000000 | 70,290 | 28 Jun 2021 | Common Stock | 70,290 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on June 28, 2022, and 1/36 of the remaining shares covered thereby vesting on the 28th day of each calendar month from July 28, 2022 through June 28, 2025, subject to continued service through each vesting date. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of common stock. |
| F3 | The Restricted Stock Unit vests and becomes exercisable in four equal installments on June 28 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Dr. D'Amour's Executive Employment Agreement, dated as of June 5, 2021 and effective as of June 28, 2021), subject to continued service through each vesting date. |
Chief Scientific Officer